American Diabetes Association 75th Scientific Sessions

American Diabetes Association 75th Scientific Sessions | ADA 2015

At the American Diabetes Association 75th Scientific Sessions, "top scientists, physicians and other health care professionals from around the world" will "share cutting-edge research, treatment recommendations and advances toward a cure for diabetes."

Conference Coverages

Q&A With Frank Brosius, MD From the University of Michigan: Treatment for Diabetic Kidney Disease Progressing with More Work to Be Done
Q&A With Frank Brosius, MD From the University of Michigan: Treatment for Diabetic Kidney Disease Progressing with More Work to Be Done VIDEO
Diabetic kidney disease does not have the telltale signs of other conditions which can make it difficult to spot. However, with the right tests patients can get the treatments they need.
Q&A With Frank Brosius, MD From the University of Michigan: How to Diagnose and Educate Others About Diabetic Kidney Disease VIDEO
Diabetic kidney disease does not have the telltale signs of other conditions which can make it difficult to spot. However, with the right tests patients can get the treatments they need.
Q&A With John Yee From AstraZeneca: Developing New Diabetes Medications and Addressing Potential issues VIDEO
One of the newest developments in the treatment of diabetes is the GLP-1 receptor agonist. With different forms intended for different populations it continues a longstanding pattern of bringing new medications into the pool of options for doctors to choose from.
Q&A With John Yee From AstraZeneca: Combination Therapies Show Promise for Diabetes Treatment VIDEO
There is no shortage of medications for type 2 diabetes but as the number of patients also increases work is underway to find the best options for everyone with the condition.
Q&A With Robert Eckel From the University of Colorado: Angina Prescription Could Help Some Patients with Diabetes VIDEO
A recent study of a medication used to help patients with angina could also help those with diabetes. How much of a benefit it can provide remains to be determined.
Q&A With Robert Eckel From the University of Colorado: Major Medical Organizations Largely Agree on New Cholesterol Guidelines VIDEO
With new medications and therapies being developed for a variety of conditions, a consistent message from the medical community can help move treatment forward.
TECOS: No Increased Cardiovascular Risk with Sitagliptin
Results from the TECOS trial indicate patients with type 2 diabetes and cardiovascular disease treated with sitagliptin are not at higher risk for cardiovascular events or hospitalization.
Q&A with Jaime Davidson from UT Southwestern: New Tool Looks to Bridge the Gap Between Latino Patients with Diabetes and Doctors VIDEO
There can be significant obstacles for healthcare professionals in the United States treating Hispanic and Latino patients, particularly when a language barrier is involved.
Q&A With Jaime Davidson From UT Southwestern: Cultural Details Important in Addressing Diabetes for Latino Community VIDEO
Diabetes is an ever growing problem in the latino community which also continues to grow in the United States. Addressing the condition in these patients is sometimes about more than just knowing the medications they require.

Most Popular

@MDMagazine

$vacMongoViewPlus$ $vAR$